| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a79688de8df300f1f33f11f39018ce0d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_4ac63cdfc1b24198277e5cb866c0afb9 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D473-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-00 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D473-06 |
| filingDate |
2003-07-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_eb05754265a90cb3c5c0680049004036 |
| publicationDate |
2004-06-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2004009594-A3 |
| titleOfInvention |
Xanthine derivatives having adenosine a1-receptor antagonist properties |
| abstract |
The subject invention provides 1,3-dipropylxanthines that have one of the following functions at the 8-position also have potent and specific properties. |
| priorityDate |
2002-07-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |